Tadalafil

Profiles of Drug Substances, Excipients and Related Methodology

Volumn 36, Issue , 2011, Pages 287-329

  Abdel Aziz, Alaa A M ^a   Asiri, Yousif A ^a   El Azab, Adel S ^a   Al Omar, Mohamed A ^a   Kunieda, Takehisa ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b SOJO UNIVERSITY   (Japan)

Author keywords

Cialis; Erectile dysfunction; PDE5 inhibitor; Sildenafil; Tadalafil; Vardenafil

Indexed keywords

12A EPITADALAFIL; 6 EPITADALAFIL; ALCOHOL; BOSENTAN; CYCLODEXTRIN; CYTOCHROME P450 ISOENZYME; GLYCERYL TRINITRATE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; POLOXAMER; SILDENAFIL; TADALAFIL; TRYPTOPHAN; UNCLASSIFIED DRUG; VARDENAFIL;

AQUEOUS SOLUTION; AREA UNDER THE CURVE; BOOK; CAPILLARY ELECTROPHORESIS; CARBON NUCLEAR MAGNETIC RESONANCE; CHIRAL CHROMATOGRAPHY; DIASTEREOISOMER; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOLERABILITY; DYSPEPSIA; EPIMERIZATION; ERECTILE DYSFUNCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; MELTING POINT; MOLECULAR WEIGHT; NONHUMAN; OPTICAL ROTATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PULMONARY HYPERTENSION; RAMAN SPECTROMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL INTERCOURSE; STEREOCHEMISTRY; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRAVIOLET SPECTROSCOPY; X RAY POWDER DIFFRACTION;

EID: 79957968576     PISSN: 18715125     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387667-6.00008-7     Document Type: Chapter

References (66)

1. Lue T.F. N. Engl. J. Med. 2000, 342:1802.
2. Gazzaruso C., Giordanetti S., De Amici E., Bertone G., Falcone C., Geroldi D., Fratino P., Solerte S.B., Garzaniti A. Circulation 2004, 110:22.
3. Bocchio M., Desideri G., Scarpelli P., Necozione S., Properzi G., Spartera C., Francavilla F., Ferri C., Francavilla S. J. Urol. 2004, 171:1601.
4. Dunn P.J. Org. Process Res. Dev. 2005, 9:88.
5. Sorbera L.A., Martin L., Leeson P.A., Castaner J. Drugs Future 2001, 26:15.
6. A.C.-M. Daugan, European Patent, EP 0740668.
7. Daugan A., Grondin P., Ruault C., Le Monnier de Gouville A.-C., Coste H., Kirilovsky J., Hyafil F., Labaudinière R. J. Med. Chem. 2003, 46:4525.
8. Daugan A., Grondin P., Ruault C., Le Monnier de Gouville A.-C., Coste H., Linget J.M., Kirilovsky J., Hyafil F., Labaudinière R. J. Med. Chem. 2003, 46:4533.
9. M.W. Orme, J.C. Sawyer, L.M. Schultze, World Patent WO 02/036593.
10. Revell J.D., Srinivasan N., Ganesan A. Synlett 2004, 1428.
11. B.B. Lohray, V.B. Lohray, S.I. Patel, World Patent WO 05/068464.
12. Montorsi F., McDermott T.E.D., Morgan R., Olsson A., Schultz A., Kirkeby H.J., Osterloh I.H. Urology 1999, 53:1011.
13. Stark S., Sachse R., Liedl T., Hensen J., Rohde G., Wensing G., Horstmann R., Schrott K.M., et al. Eur. Urol. 2001, 40:181.
14. Patterson B., Bedding A., Jewell H., Payne C., Mitchell M. Eur. Urol. Suppl. 2002, 1:152.
15. Corbin J.D., Francis S.H. Int. J. Clin. Pract. 2002, 56:453.
16. Manallack D.T., Hughes R.A., Thompson P.E. J. Med. Chem. 2005, 48:3449.
17. Xiao-Xin S., Shi-Ling L., Wei X., Yu-Lan X. Tetrahedron Asymmetr. 2008, 19:435.
18. Merck index 2006, 14th edition pages 1550-1551.
19. Graham N.M., Charlotte M.N.A., Eugene G., William A.M. Bioorg. Med. Chem. Lett. 2003, 13:1425.
20. Zhang Y., He Q., Ding H., Wu X., Xie Y. Org. Prep. Proced. Int. 2005, 37:99.
21. Jiang W., Alford V.C., Qiu Y., Bhattacharjee S., John T.M., Haynes-Johnson D., Kraft P.J., Lundeen S.J., Sui Z. Bioorg. Med. Chem. 2004, 12:1505.
22. D. Ben-Zion, D. Dov, United States Patent, US 2006/0276652 A1, 2006.
23. B.D. Pandurang, B.B. Bharat, S.S. Sachin, P.S. Pranay, United States Patent, US 7, 223, 863 B2, 2007.
24. Sen X., Xiao-Xin S., Jing X., Jing-Jing Y., Shi-Ling L., Wei-Dong L. Tetrahedron Asymmetr. 2009, 20:2090.
25. Xiao S., Lu X., Shi X.-X., Sun Y., Liang L.-L., Yu X.-H., Dong J. Tetrahedron Asymmetr. 2009, 20:430.
26. Sajiki H. Tetrahedron Lett. 1995, 36:3465.
27. Meienhofer J., Kuromizu K. Tetrahedron Lett. 1974, 15:3259.
28. Mazaleyrat J.-P., Xie J., Wakselman M. Tetrahedron Lett. 1992, 33:4301.
29. Xiaolan Z., Song X., Bo C., Fei Z., Shouzhuo Y., Zutian W., Dajin Y., Hongwei H. J. Chromatogr. A 2005, 1066:89.
30. Hassan Y.A.-E., Imran A. Talanta 2005, 65:276.
31. Imran A., Hassan Y.A.-E. Chromatographia 2004, 60:187.
32. Rodríguez Flores J., Berzas Nevado J.J., Castañeda Peñalvo G., Mora Diez N. J. Chromatogr. B 2004, 811:231.
33. Ching-Ling C., Chen-Hsi C. J. Chromatogr. B 2005, 822:278.
34. Shaimaa M.B.-E., Seham A.E., Mahmoud M.G. Eur. J. Pharm. Biopharm. 2008, 70:819.
35. Cinzia A.V., Ignazio G., Teresa M., Rosario P., Lorella R., Carla L., Claudio M., Donatella P., Giovanni P. Eur. J. Med. Chem. 2006, 41:233.
36. Crupi V., Ficarra R., Guardo M., Majolino D., Stancanelli R., Venuti V. J. Pharm. Biomed. Anal. 2007, 4:110.
37. Vikrant V., Pankajkumar S., Poonam K., Manali S., Yogesh P. Acta Pharm. 2009, 59:453.
38. Mohsen A.B., Khalid A.A., Abdulaziz A.A.-A. Int. J. Pharm. 2002, 243:107.
39. Jiradej M., Maria G.A., Kuncoro F., Aranya M. Int. J. Pharm. 2005, 293:235.
40. Laura S.S.R., Domingos C.F., Francisco J.B.V. Eur. J. Pharm. Sci. 2003, 20:253.
41. Veiga M.D., Díaz P.J., Ahsan F. J. Pharm. Sci. 1998, 87:891.
42. Robert O.W., Vorapann M., Mongkol S. Eur. J. Pharm. Biopharm. 1998, 46:355.
43. Redenti E., Peveri T., Zanol M., Ventura P., Gnappi G., Montenero A. Int. J. Pharm. 1996, 129:289.
44. Shakya A.K., Abu-awwad A.N., Arafat T.A., Melhim M. J. Chromatogr. B 2007, 852:403.
45. Peng Z., Sharon S.-Y.O., Peiling H., Min-Yong L., Hwee-Ling K. J. Chromatogr. A 2006, 1104:113.
46. Ramakrishna N.V., Vishwottam K.N., Puran S., Koteshwara M., Manoj S., Santosh M., Chidambara J., Wishu S., Sumatha B. J. Chromatogr. B 2004, 809:243.
47. Gao W., Zhang Z., Li Z., Liang G. J. Chromatogr. Sci. 2007, 45:540.
48. Madhavi A., Reddy G.S., Suryanarayana M.V., Naidu A. Chromatographia 2008, 67:633.
49. Venhuis B.J., Zomer G., Vredenbregt M.J., de Kaste D. J. Pharm. Biomed. Anal. 2010, 51:723.
50. Trefi S., Routaboul C., Hamieh S., Gilard V., Malet-Martino M., Martino R. J. Pharm. Biomed. Anal. 2008, 47:103.
51. Stéphane B., Saleh T., Véronique G., Myriam M.-M., Robert M., Marc-André D. J. Pharm. Biomed. Anal. 2009, 50:602.
52. Hartmut P. EAU Update Series 2004, 2:56.
53. Allen D.S. Clin. Cardiol. 2004, 27:I-14.
54. Giuliano F., Varanese L. Eur. Heart J. Suppl. 2002, 4:H24.
55. Mitsi A.B., Alfreda B., Roya Z., Konjeti R.S., Emmanuel P.B., Sharron H.F., Jackie D.C. Mol. Pharmacol. 2004, 66:144.
56. Brock G.B., McMahon C.G., Chen K.K., Costigan T., Shen W., Watkins V., Anglin G., Whitaker S. J. Urol. 2002, 168:1332.
57. Emmick J., Mitchell M., Bedding A. Eur. Urol. Suppl. 2003, 2:95.
58. Robert K., Jeff E., Alun B., Dennis H. J. Am. Colleg. Card. 2002, 39(Suppl. 2):291.
59. Porst H. Int. J. Impot. Res. 2002, 14(Suppl. 1):S57.
60. Sussman D.O. J. Am. Osteopath. Assoc. 2004, 104:11S.
61. Ring B.J., Patterson B.E., Mitchell M.I., Vandenbranden M., Gillespie J., Bedding A.W., Jewell H., Payne C.D., Forgue S.T., Eckstein J., Wrighton S.A., Phillips D.L. Clin. Pharmacol. Ther. 2005, 77:63.
62. Carson C.C., Rajfer J., Eardley I., Carrier S., Denne J.S., Walker D.J., Shen W. BJU Int. 2004, 93:1276.
63. Forgue S.T., Patterson B.E., Bedding A.W., Payne C.D., Phillips D.L., Wrishko R.E., et al. Br. J. Clin. Pharmacol. 2006, 61:280.
64. B. Gerald, Europ. Urology Supp. 1, 2002, 12.
65. Trocóniz I.F., Tillmann C., Staab A., Rapado J., Forgue S.T. Eur. J. Clin. Pharmacol. 2007, 63:583.
66. Wrishko R.E., Dingemanse J., Yu A., Darstein C., Phillips D.L., Mitchell M.I. J. Clin. Pharmacol. 2008, 48:610.